Novo Nordisk A/s

Antyra Inc.

Michael Lennick

Neil I Goldstein

Arthur J Blume

Renee Brissette

Ku-chuan Hsiao

Hao Liu

Renuka Pillutla

Olga Dedova

Paul Fletcher

Pinger Wang

Peptide sequences capable of binding to insulin and/or insulin-like growth factor receptors with either agonist or antagonist activity and identified from various peptide libraries are disclosed. This invention also identifies at least two different binding sites, which are present on insulin and insulin-like growth factor receptors, and which selectively bind the peptides of this invention. As agonists, the peptides of this invention may be useful for development as therapeutics to supplement or replace endogenous peptide hormones. The antagonist peptides may also be developed as therapeutics.

Insulin and IGF-1 receptor agonists and antagonists

Growing community of inventors

Exton, PA, United States of America

Michael Lennick